Primary Results of NRG-RTOG1106/ECOG-ACRIN 6697: A Randomized Phase II Trial of Individualized Adaptive (chemo)Radiotherapy Using Midtreatment 18 F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Stage III Non–Small Cell Lung Cancer is a research paper published in Journal of Clinical Oncology (2024). On theSindex it has a DataRank of 1.1. It has been cited 39 times, with 37 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.553
From this paper's citation signal
Citation Network Contribution
0.555
From 19 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 37 citers.
NCI NIH HHS
Grant: P30 CA008748
NCI NIH HHS
Grant: UG1 CA189851
NCI NIH HHS
Grant: U10 CA180820
NCI NIH HHS
Grant: U10 CA180868
NCI NIH HHS
Grant: U24 CA180803
NCI NIH HHS
Grant: UG1 CA233234
NCI NIH HHS
Grant: UG1 CA233290
NCI NIH HHS
Grant: UG1 CA233339
NCI NIH HHS
Grant: U10 CA180822
NCI NIH HHS
Grant: UG1 CA233160
NCI NIH HHS
Grant: R01 CA142840
NCI NIH HHS
Grant: UG1 CA233196
NCI NIH HHS
Grant: UG1 CA233247
NCI NIH HHS
Grant: U10 CA180794
NCI NIH HHS
Grant: U24 CA196067
NCI NIH HHS
Grant: UG1 CA189867
NCI NIH HHS
Grant: P30 CA091842
FWCI
11.77
Citation Percentile
1.0%
Influential Citations
1
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals